↓ Skip to main content

Lack of EGFR mutations benefiting gefitinib treatment in adenocarcinoma of esophagogastric junction

Overview of attention for article published in World Journal of Surgical Oncology, January 2012
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age and source (60th percentile)

Mentioned by

twitter
2 X users

Citations

dimensions_citation
15 Dimensions

Readers on

mendeley
27 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Lack of EGFR mutations benefiting gefitinib treatment in adenocarcinoma of esophagogastric junction
Published in
World Journal of Surgical Oncology, January 2012
DOI 10.1186/1477-7819-10-14
Pubmed ID
Authors

Wen-Ping Wang, Kang-Ning Wang, Qiang Gao, Long-Qi Chen

Abstract

The epidermal growth factor receptor (EGFR) inhibitor, gefitinib, has been reported to successfully treat advanced non-small cell lung cancer patients with genetic mutations in EGFR. The aim of this study was to investigate the existence of EGFR mutations in carcinoma of esophagogastric junction, and also to explore the possibility of treating carcinoma of esophagogastric junction using gefitinib.

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 27 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 27 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 6 22%
Student > Ph. D. Student 4 15%
Researcher 4 15%
Student > Master 4 15%
Other 2 7%
Other 5 19%
Unknown 2 7%
Readers by discipline Count As %
Medicine and Dentistry 16 59%
Agricultural and Biological Sciences 4 15%
Biochemistry, Genetics and Molecular Biology 2 7%
Nursing and Health Professions 1 4%
Unknown 4 15%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 17 January 2012.
All research outputs
#15,241,259
of 22,661,413 outputs
Outputs from World Journal of Surgical Oncology
#613
of 2,038 outputs
Outputs of similar age
#162,848
of 245,786 outputs
Outputs of similar age from World Journal of Surgical Oncology
#15
of 61 outputs
Altmetric has tracked 22,661,413 research outputs across all sources so far. This one is in the 22nd percentile – i.e., 22% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,038 research outputs from this source. They receive a mean Attention Score of 2.0. This one has gotten more attention than average, scoring higher than 56% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 245,786 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 22nd percentile – i.e., 22% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 61 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 60% of its contemporaries.